ATE403417T1 - Pharmazeutische zusammensetzung enthaltend eine wasser/öl/wasser doppelte mikroemulsion in einem festen träger - Google Patents

Pharmazeutische zusammensetzung enthaltend eine wasser/öl/wasser doppelte mikroemulsion in einem festen träger

Info

Publication number
ATE403417T1
ATE403417T1 AT02795221T AT02795221T ATE403417T1 AT E403417 T1 ATE403417 T1 AT E403417T1 AT 02795221 T AT02795221 T AT 02795221T AT 02795221 T AT02795221 T AT 02795221T AT E403417 T1 ATE403417 T1 AT E403417T1
Authority
AT
Austria
Prior art keywords
water
oil
pharmaceutical composition
composition containing
solid carrier
Prior art date
Application number
AT02795221T
Other languages
English (en)
Inventor
Fabio Carli
Elisabetta Chiellini
Original Assignee
Geotech Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geotech Pharma Inc filed Critical Geotech Pharma Inc
Application granted granted Critical
Publication of ATE403417T1 publication Critical patent/ATE403417T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02795221T 2001-12-19 2002-12-18 Pharmazeutische zusammensetzung enthaltend eine wasser/öl/wasser doppelte mikroemulsion in einem festen träger ATE403417T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI002694A ITMI20012694A1 (it) 2001-12-19 2001-12-19 Composizione farmaceutica comprendente una microemulsione doppia olio/acqua/olio incorporata in un supporto solido

Publications (1)

Publication Number Publication Date
ATE403417T1 true ATE403417T1 (de) 2008-08-15

Family

ID=11448712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02795221T ATE403417T1 (de) 2001-12-19 2002-12-18 Pharmazeutische zusammensetzung enthaltend eine wasser/öl/wasser doppelte mikroemulsion in einem festen träger

Country Status (9)

Country Link
US (1) US20050147659A1 (de)
EP (1) EP1467710B1 (de)
JP (1) JP2005517652A (de)
AT (1) ATE403417T1 (de)
AU (1) AU2002361005A1 (de)
CA (1) CA2470590A1 (de)
DE (1) DE60228129D1 (de)
IT (1) ITMI20012694A1 (de)
WO (1) WO2003051334A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851918B1 (fr) * 2003-03-06 2006-06-16 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
JP5050322B2 (ja) * 2005-06-21 2012-10-17 三菱化学株式会社 含油固形物およびその製造方法
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
EP1867323A1 (de) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmazeutische Zusammensetzungen mit verbesserter Permeation durch biologische Barrieren
JP5110848B2 (ja) * 2006-07-14 2012-12-26 富士カプセル株式会社 ジフェンヒドラミン塩含有製剤
CA2669094A1 (en) * 2006-11-08 2008-05-29 Novavax,Inc. Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
EP3082767B1 (de) 2013-12-17 2024-09-25 Zim Laboratories Limited Pharmazeutische mikroemulsionsimmobilisierte in einer dünnen polymermatrix und verfahren zur herstellung davon
CA2987177A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once-daily oral pharmaceutical composition of isotretinoin
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CN110330014B (zh) * 2019-07-16 2022-07-08 兰州理工大学 用于超级电容器电极材料的淀粉多孔碳微球的制备方法
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
US5332595A (en) * 1991-03-18 1994-07-26 Kraft General Foods, Inc. Stable multiple emulsions comprising interfacial gelatinous layer, flavor-encapsulating multiple emulsions and low/no-fat food products comprising the same
US5756719A (en) * 1996-09-03 1998-05-26 Basf Corporation Double emulsion techniques for making novel compositions containing gluten and polysaccharides that contain uronic acid residues useful for encapsulating fats, oils and solids
JP4815053B2 (ja) * 1998-08-13 2011-11-16 シーマ・ラブス、インコーポレイテッド 経口投与の固形投与形態物としてのマイクロエマルション
DE60020738T2 (de) * 1999-12-23 2006-03-16 Adisseo France S.A.S. Teilchenförmige vitaminzubereitung

Also Published As

Publication number Publication date
CA2470590A1 (en) 2003-06-26
WO2003051334A3 (en) 2003-12-31
WO2003051334A2 (en) 2003-06-26
AU2002361005A1 (en) 2003-06-30
JP2005517652A (ja) 2005-06-16
US20050147659A1 (en) 2005-07-07
EP1467710B1 (de) 2008-08-06
ITMI20012694A1 (it) 2003-06-19
EP1467710A2 (de) 2004-10-20
DE60228129D1 (de) 2008-09-18

Similar Documents

Publication Publication Date Title
DE60228129D1 (de) Pharmazeutische zusammensetzung enthaltend eine wasser/öl/wasser doppelte mikroemulsion in einem festen träger
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
BR0211317A (pt) Sistema para a liberação controlada de uma droga por meio de retenção gástrica
DE69914787D1 (de) Flüssige zusammensetzungen mit kontrollierter freigabe mit niedrigem initialfreisetzungsstoss des wirkstoffs
WO2003032953A1 (en) Granules containing acid-unstable chemical in large amount
ATE258750T1 (de) Freisetzungssystem von cyclopropenderivaten
EP2415760A3 (de) CCR-9-Antagonisten
DE60218885D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung enthaltend 5,8,14-triazatetracyclo (10.3.1.0(2,11) 0 (4,9) )-hexadeca-2(11) 3, 5,7, 9-pentaene
DE50208214D1 (de) Saure hochquellfähige hydrogele
DE60321386D1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
EA199900749A1 (ru) Фармацевтическая композиция
ATE395906T1 (de) Träger in partikelform zur verbesserung der oral- absorption von wikstoffen
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
DK1389213T3 (da) 3,7-Diazabicyclo[3.3.1]formuleringer som antiarytmiske forbindelser
BRPI0401103A (pt) Composição compósita, método para formar a mesma, composição modificada, e, método para formar a mesma
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
BR0312814A (pt) Levamisol / avermectinas ou similares em solvente de pirrolidona
DE69706146D1 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
IL174655A0 (en) Drug containing (2r)-2-propyloctanoic acid as the active ingredient
DE60219650D1 (de) Pharmazeutische zusammensetzung enthaltend eine wasser/öl/wasser doppelte mikroemulsion in einem festen träger
ID21282A (id) Senyawa-senyawa cincin beranggota-5 terpadu yang disubstitusi sulfonamida, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung senyawa tersebut
DE60121293D1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
ATE307579T1 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen
EA200400343A1 (ru) Композиция с контролируемым высвобождением кларитромицина или тинидазола

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties